Literature DB >> 6260834

Comparison of direct immunofluorescent staining of clinical specimens for respiratory virus antigens with conventional isolation techniques.

L Minnich, C G Ray.   

Abstract

Staining of clinical respiratory specimens obtained by nasopharyngeal and throat swabs with direct fluorescein isothiocyanate-conjugated antisera to para-influenza virus types 1, 2, and 3, influenza A virus, respiratory syncytial virus, adenovirus, mumps virus, and measles virus was compared with isolation procedures in routine tissue culture systems. Direct staining of clinical specimens with the commercially available conjugated offered a rapid means of diagnosing respiratory infections on a routine clinical basis when used in conjunction with isolation in tissue culture systems. Of 292 patients who were culture positive for these viruses, 259 were diagnosed by detection of the viral antigen in clinical specimens by direct immunofluorescence. No specimens that subsequently yielded a different respiratory virus by culture were positive by the direct immunofluorescence method. Use of selected antisera based on clinical history of the patient reduced the cost of rapid viral diagnosis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6260834      PMCID: PMC273594          DOI: 10.1128/jcm.12.3.391-394.1980

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Immunofluorescent diagnosis of acute viral infection.

Authors:  V Knight; F Brasier; S B Greenberg; D B Jones
Journal:  South Med J       Date:  1975-06       Impact factor: 0.954

2.  Immunofluorescent detection of adenovirus antigen in epidemic keratoconjunctivitis.

Authors:  H S Schwartz; D W Vastine; H Yamashiroya; C E West
Journal:  Invest Ophthalmol       Date:  1976-03

3.  The use of immunofluorescence in the laboratory diagnosis of influenza type B.

Authors:  B Bjorvatn; S Wolontis
Journal:  Scand J Infect Dis       Date:  1972

4.  Rapid identification of viruses by indirect immunofluorescence: standardization and use of antiserum pool to nine respiratory viruses.

Authors:  T D Stevens; H M Watkins
Journal:  Appl Microbiol       Date:  1969-03

5.  Rapid diagnosis of respiratory syncytial virus infection by immunofluorescent antibody techniques.

Authors:  J McQuillin; P S Gardner
Journal:  Br Med J       Date:  1968-03-09

6.  Rapid detection and identification of respiratory viruses by direct immunofluorescence.

Authors:  D D'Alessio; S Williams; E C Dick
Journal:  Appl Microbiol       Date:  1970-08

7.  Immunofluorescence in diagnosis of measles infections in children.

Authors:  R E Fulton; P J Middleton
Journal:  J Pediatr       Date:  1975-01       Impact factor: 4.406

8.  Observations on clinical and immunofluorescent diagnosis of parainfluenza virus infections.

Authors:  P S Gardner; J McQuillin; R McGuckin; R K Ditchburn
Journal:  Br Med J       Date:  1971-04-03

9.  Comparison of immunofluorescence and isolation techniques in the diagnosis of respiratory viral infections of children.

Authors:  R E Fulton; P J Middleton
Journal:  Infect Immun       Date:  1974-07       Impact factor: 3.441

10.  The late detection of respiratory syncytial virus in cells of respiratory tract by immunofluorescence.

Authors:  P S Gardner; J McQuillin; R McGuckin
Journal:  J Hyg (Lond)       Date:  1970-12
View more
  38 in total

1.  SimulFluor respiratory screen for rapid detection of multiple respiratory viruses in clinical specimens by immunofluorescence staining.

Authors:  M L Landry; D Ferguson
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Comparison of enzyme-linked immunosorbent assay, indirect immunofluorescence assay, and virus isolation for detection of respiratory viruses in nasopharyngeal secretions.

Authors:  S Takimoto; M Grandien; M A Ishida; M S Pereira; T M Paiva; T Ishimaru; E M Makita; C H Martinez
Journal:  J Clin Microbiol       Date:  1991-03       Impact factor: 5.948

3.  Comparison of directigen RSV with viral isolation and direct immunofluorescence for the identification of respiratory syncytial virus.

Authors:  J L Waner; N J Whitehurst; S J Todd; H Shalaby; L V Wall
Journal:  J Clin Microbiol       Date:  1990-03       Impact factor: 5.948

Review 4.  Detection of infection or infectious agents by use of cytologic and histologic stains.

Authors:  G L Woods; D H Walker
Journal:  Clin Microbiol Rev       Date:  1996-07       Impact factor: 26.132

5.  Practical recommendations for the detection of pediatric respiratory syncytial virus infections.

Authors:  M W Treuhaft; J M Soukup; B J Sullivan
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

6.  Evaluation of a solid-phase immunoassay with fluorescein isothiocyanate-conjugated heterogeneous or monoclonal antibodies for identification of virus isolates, with influenza virus as a model.

Authors:  D J Phillips; G G Galland; C B Reimer; A P Kendal
Journal:  J Clin Microbiol       Date:  1982-05       Impact factor: 5.948

7.  Rapid diagnosis of respiratory syncytial virus infection by antigen immunofluorescence detection with monoclonal antibodies and immunoglobulin M immunofluorescence test.

Authors:  Z Kadi; S Dali; S Bakouri; A Bouguermouh
Journal:  J Clin Microbiol       Date:  1986-12       Impact factor: 5.948

8.  Evaluation of the Abbott TESTPACK RSV enzyme immunoassay for detection of respiratory syncytial virus in nasopharyngeal swab specimens.

Authors:  E M Swierkosz; R Flanders; L Melvin; J D Miller; M W Kline
Journal:  J Clin Microbiol       Date:  1989-06       Impact factor: 5.948

9.  Use of egg-yolk antibody for detection of respiratory syncytial virus in nasal secretions by ELISA.

Authors:  M Zrein; G Obert; M H van Regenmortel
Journal:  Arch Virol       Date:  1986       Impact factor: 2.574

10.  Detection of respiratory virus antigens in nasopharyngeal secretions from patients with acute respiratory disease by radio-immunoassay and tissue culture isolation.

Authors:  L Ehrlicher; H G Hoffmann; K O Habermehl
Journal:  Med Microbiol Immunol       Date:  1984       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.